Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D2FCM4
|
|||
| Drug Name |
VB 1953
|
|||
| Indication | Acne vulgaris [ICD-11: ED80; ICD-10: L70.0; ICD-9: 706.1] | Phase 2 | [1] | |
| Company |
Vyome Therapeutics
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Bacterial DNA gyrase (Bact gyrase) | Target Info | Inhibitor | [2] |
| Bacterial DNA topoisomerase 4A (Bact parC) | Target Info | Inhibitor | [2] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03900676) Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Vyome Therapeutics. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.